XNCR Xencor, Inc.
Healthcare$11.60+0.00%OpenMarket Cap: $859.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.65
P/S
8.61
EV/EBITDA
-11.68
DCF Value
$-6.26
FCF Yield
-22.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
92.0%
Operating Margin
-217.9%
Net Margin
-177.1%
ROE
-28.8%
ROA
-23.4%
ROIC
-30.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $4.5M | 43.2% | $-77.9M | $-128.9M | $— | — |
| Q4 null | $28.2M | 90.9% | $-53.6M | $-6.7M | $— | — |
| FY null | $125.6M | 91.6% | $-177.5M | $-91.9M | $— | — |
| Q3 null | $21.0M | 100.0% | $-47.5M | $-6.0M | $— | — |
| Q2 null | $43.6M | 93.9% | $-33.2M | $-30.8M | $— | — |
| Q1 null | $32.7M | 91.8% | $-43.2M | $-48.4M | $— | — |
| Q4 null | $70.0M | 100.0% | $4.0M | $-53.5M | $— | — |
| FY null | $110.5M | 100.0% | $-178.4M | $-232.6M | $— | — |
| Q3 null | $17.8M | 100.0% | $-55.2M | $-46.3M | $— | — |
| Q2 null | $17.0M | 82.2% | $-62.3M | $-66.0M | $— | — |
| Q1 null | $16.0M | 100.0% | $-54.7M | $-73.4M | $— | — |
| Q4 2023 | $51.0M | 93.7% | $-28.7M | $-26.1M | $-0.43 | — |